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Genotype-specific effects of Mecp2
loss-of-function on morphology of
Layer V pyramidal neurons in
heterozygous female Rett syndrome
model mice
Leslie Rietveld, David P. Stuss†, David McPhee and Kerry R. Delaney*
Department of Biology, University of Victoria, Victoria, BC, Canada
Rett syndrome (RTT) is a progressive neurological disorder primarily caused by
mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2). The
heterozygous female brain consists of mosaic of neurons containing both wild-type
MeCP2 (MeCP2+) and mutant MeCP2 (MeCP2−). Three-dimensional morphological
analysis was performed on individually genotyped layer V pyramidal neurons in
the primary motor cortex of heterozygous (Mecp2+/−) and wild-type (Mecp2+/+)
female mice ( tm1 1Jae> 6 mo.) from the Mecp2 . line. Comparing basal dendrite
morphology, soma and nuclear size of MeCP2+ to MeCP2− neurons reveals a
significant cell autonomous, genotype specific effect of Mecp2. MeCP2− neurons
have 15% less total basal dendritic length, predominantly in the region 70–130 µm
from the cell body and on average three fewer branch points, specifically loss in
the second and third branch orders. Soma and nuclear areas of neurons of mice
were analyzed across a range of ages (5–21 mo.) and X-chromosome inactivation
(XCI) ratios (12–56%). On average, MeCP2− somata and nuclei were 15 and
13% smaller than MeCP2+ neurons respectively. In most respects branching
morphology of neurons in wild-type brains (MeCP2 WT) was not distinguishable
from MeCP2+ but somata and nuclei of MeCP2 WT neurons were larger than
those of MeCP2+ neurons. These data reveal cell autonomous effects of Mecp2
mutation on dendritic morphology, but also suggest non-cell autonomous effects
with respect to cell size. MeCP2+ and MeCP2− neuron sizes were not correlated
with age, but were correlated with XCI ratio. Unexpectedly the MeCP2− neurons
were smallest in brains where the XCI ratio was highly skewed toward MeCP2+,
i.e., wild-type. This raises the possibility of cell non-autonomous effects that act
through mechanisms other than globally secreted factors; perhaps competition
for synaptic connections influences cell size and morphology in the genotypically
mosaic brain of RTT model mice.
Keywords: pyramidal neuron, Sholl analysis, dendrites, Rett syndrome, female mouse, X-linked genetic disease,
MeCP2
Frontiers in Cellular Neuroscience | www.frontiersin.org 1 April 2015 | Volume 9 | Article 145
Rietveld et al. Neuron morphology Rett syndrome mice
Introduction
Rett Syndrome (RTT) is a postnatal neurological disorder that
was ﬁrst characterized by Rett (1966). It aﬀects approximately
one in 10,000 live female births (Laurvick et al., 2006). Typical
RTT patients are diagnosed after a period of normal develop-
ment (6–18 months of age) followed by a period of regression
marked by four main criteria: partial or complete loss of purpose-
ful hand movements, development of gait abnormalities, loss of
verbal language skills and the presence of stereotypic hand move-
ments (Neul et al., 2010). The majority of females with RTT are
heterozygous for a mutation in the X-linked gene Methyl-CpG-
binding Protein 2 (MECP2; Amir et al., 1999). Normally,MECP2
expression levels are low prenatally, but increase after birth dur-
ing the ﬁnal stages of neurogenesis (Balmer et al., 2003; Kishi
and Macklis, 2004; Skene et al., 2010), supporting the observa-
tion that MeCP2 contributes to neuronal dendritic maturation
and synaptogenesis (Armstrong et al., 1995; Kishi and Macklis,
2004; Fukuda et al., 2005). Although over 1000 mutations have
been characterized along the entire length of the gene, including
nonsense, missense, frameshift, and large truncation mutations
(Amir and Zoghbi, 2000; Weaving et al., 2005; Philippe et al.,
2006; Cuddapah et al., 2014), 65% of RTT cases are caused by
eight common missense mutations in the region that encodes the
methyl-CpG binding domain (MDB) of MeCP2 (Miltenberger-
Miltenyi and Laccone, 2003).
The protein encoded by theMECP2 gene has ﬁve key domains
including a highly conserved MDB characteristic of its protein
family, a transcriptional repressor domain, which interacts with
histone deacetylases 1 and 2 to promote chromatin condensation,
and a C-terminal domain, which contributes to DNA-binding
(Chandler et al., 1999). Phenotype/genotype studies have found
that early N-terminal truncation mutations that aﬀect the MBD
are correlated with a more severe phenotype than late C-terminal
truncation mutations (Zappella et al., 2001; Charman et al., 2005;
Cuddapah et al., 2014). The Mecp2tm1.1Jae mice used in this
study have exon 3 deleted, which comprises most of the MBD.
The resulting translated mutant protein may be partly functional
(Stuss et al., 2013), leading to a milder phenotype in these ani-
mals than has been observed in total knockouts (Belichenko et al.,
2009), but still resulting in severe neuropathic symptoms similar
to the human condition (Chen et al., 2001).
MeCP2 is found in many tissue types, but it is most abundant
in the brain, with expression levels in neuronal nuclei ten times
higher than in glia (Skene et al., 2010).MECP2 is located on the X-
chromosome and therefore it is aﬀected by X-chromosome inac-
tivation (XCI; Adler et al., 1995; Ross et al., 2005). XCI occurs in
early embryogenesis (gastrulation in humans), randomly inacti-
vating either the maternal or paternal X-chromosome in each cell
and passing this status on to all future progeny (Bermejo-Alvarez
et al., 2012). XCI therefore results in two populations of neurons
in RTT females: those expressing wild-type MeCP2 (MeCP2+),
and those that lack fully functional MeCP2 (MeCP2−) Although
the majority of human patients with typical RTT have nearly bal-
anced XCI ratios (Shahbazian et al., 2002), the rate of skewed
XCI ratios is nonetheless higher in patients with X-linked disor-
ders such as RTT than in the general population. When skewing
occurs it usually favors wild-type over mutant cells (Belmont,
1996; Puck and Willard, 1998; Brown and Robinson, 2000) and
XCI ratios follow a similar pattern in mice (Young and Zoghbi,
2004).
Rett syndrome patients deﬁcient in MeCP2 have reduced
gray matter volume in the frontal and temporal lobes, caudate
nucleus, thalamus, midbrain, and cerebellum (Reiss et al., 1993;
Subramaniam et al., 1997). Volume reductions in the frontal and
temporal lobes have been found to be predictive of phenotype
severity in RTT (Carter et al., 2008). Neurodegeneration has not
been observed in forebrain (Armstrong, 1995), and the symptoms
of RTT in transgenic mice can be reversed even in adulthood
(Luikenhuis et al., 2004; Guy et al., 2007, 2010) suggesting that
RTT is caused by a defect in neurological function rather than
by neuronal damage (McGraw et al., 2011). Morphological stud-
ies performed on post-mortem tissue from both RTT patients
and mouse models have revealed that the reduction in brain vol-
ume is accompanied by increased neuron density associated with
reductions in neuronal cell body size (Bauman et al., 1995; Chen
et al., 2001; Goﬃn et al., 2011; Wang et al., 2013). It has also
been found that RTT patients have reduced dendritic arboriza-
tion and spine density of Layer II/III and V/VI pyramidal cells
in the frontal and temporal areas, including the motor cortex
(Belichenko et al., 1994, 1997). Similar reductions in spine den-
sity have been reported for hippocampal CA1 neurons of RTT
patients (Chapleau et al., 2009).
Most animal studies have used Mecp2 mutant male mice
(Mecp2−/y), since their juvenile symptom onset and rapid pro-
gression mirrors RTT patients and shortens the time required
for experimental studies. As well, since Mecp2−/y mice express
mutant MeCP2 in all cells, variations in XCI ratio between indi-
viduals are not a potential complication. However, these studies
may not address distinct eﬀects that occur in the mosaic brain
environment of heterozygous females. Mecp2+/− mice display
the same RTT-like neuropathological and motor abnormalities as
Mecp2−/y mice, but these symptoms are normally only begin to
become apparent after 4–6months of age, compared to 3–5 weeks
for male mice, with some female mice even living a normal
lifespan (Chen et al., 2001; Guy et al., 2001, 2007; Bissonnette
and Knopp, 2006; Bissonnette et al., 2007; Abdala et al., 2010).
However, progressive motor deﬁcits, reduced anxiety, apnea, and
weight gain have been described in Mecp2+/− mice as young as
3–4 weeks old (Santos et al., 2007; Samaco et al., 2009, 2012),
which are largely pre-symptomatic for the more readily observed
motor abnormalities.
The mosaic brain environment of the female Mecp2+/−
mouse prompts the following question: are the cellular pheno-
types of MeCP2+ and MeCP2− neurons determined by their
individual genotype (cell autonomy) or by the surrounding envi-
ronment, including neural and non-neuronal cells (non-cell-
autonomy), or both?
Our laboratory recently investigated the morphology of pyra-
midal neurons in the primary motor cortex ofMecp2tm1.1Jae male
mice using the YFP-H transgenic mouse line (Feng et al., 2000) to
visualize morphology. We found that Mecp2−/y basal and api-
cal dendritic arbors are reduced in length, and that Mecp2−/y
spine density is selectively reduced on the apical tuft and on
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oblique apical dendrites (Stuss et al., 2012). The aim of the cur-
rent study is to investigate how a mutation in Mecp2 aﬀects the
morphology of both neuronal genotypes in a female Mecp2+/−
brain. We examined the morphology of basal dendrites, as well
as the sizes of soma and nuclei in Layer V pyramidal neurons
of the primary motor cortex, using single-cell microinjection of
Alexa Fluor 594 with DAPI and NeurotraceTM counterstains.
Neuronal genotypes were determined by immunohistochem-
istry. For this study MeCP2− is used to indicate neurons within
the brain of Mecp2+/− animals that express mutant MeCP2,
MeCP2+ refers to neurons expressing wild-type MeCP2 and
MeCP2WT denotes neurons in wild-type female brain. Reduced
branching was observed primarily within 30–70 µm of the soma
in MeCP2− neurons. In most respects dendritic structures of
MeCP2+ neurons were not distinguishable from MeCP2 WT
neurons, indicating predominantly cell-autonomous eﬀects of
the mutation on dendrite branching. Within-animal comparisons
showed that soma and nuclear sizes of MeCP2− neurons were
reduced compared to MeCP2+ neurons, consistent with cell-
autonomous eﬀects. Between-animal comparisons revealed that
MeCP2 WT somata were larger than MeCP2+, suggesting an
additional non-cell-autonomous eﬀect. Intriguingly, the ratio of
MeCP2− to MeCP2+ soma and nuclear size was negatively cor-
related with XCI. The diﬀerence in size was greatest when the
proportion of MeCP2− neurons was low (highly skewed XCI),
which may indicate an additional negative environmental eﬀect
for MeCP2− neurons when they are in the minority or a reduced
ability of MeCP2− neurons to beneﬁt from a predominantly
wild-type brain environment.
Materials and Methods
Experimental Animals
Heterozygous Mecp2+/− female mice (Mecp2tm1.1Jae/Mmcd;
MMRRC, UC Davis; Chen et al., 2001) were maintained on a
C57BL/6 background and their wild-type littermates (Mecp2+/+)
were used as controls for soma and nuclear size analysis.
Mecp2+/− females were crossed with homozygous male YFP-
H mice [B6.Cg-Tg(Thy1-YFPH)2Jrs/J; Feng et al., 2000], which
were also maintained on a C57BL/6 background, to generate
female oﬀspring heterozygous for bothMecp2 and YFP-H. These
oﬀspring (Mecp2+/−/YFP+/−) and their wild-type littermates
(Mecp2+/+/YFP+/−) were used for single-cell microinjection
experiments. YFP expression observed with blue excitation con-
ﬁrmed the location of Layer 5 neurons for injection with Alexa
594. All animals were housed in the University of Victoria Animal
Care Unit in compliance with the guidelines established by the
Canadian Council on Animal Care and Use with approval of pro-
tocols by the University Animal Care Committee. Animals were
kept at 21 ± 2◦C under a 12 h light/dark cycle with limited envi-
ronmental enrichment, and were fed standard laboratory diet and
water ad libitum. Mecp2 status was determined by genotyping
(Stuss et al., 2012).
Prior to tissue extraction a phenotypic score was calculated by
summing the severity scores for 6 characteristics (in parentheses)
in Table 1. Mice were then anesthetized and transcardially per-
fused with 10 ml of room temperature 0.1 M phosphate buﬀered
saline (PBS) pH 7.4 for exsanguination (10 ml/min).
For mice prepared for single-cell microinjections, PBS per-
fusion was followed by 30 ml of 4% paraformaldehyde (4%
PFA) in 0.1 M phosphate buﬀer, pH 6.5, at a rate of 5 ml/min.
After removal from the cranium, the brain was post-ﬁxed in 4%
PFA, pH 6.5, for 10 min at RT. Following this, the brain was
removed and placed in a weigh boat for up to 15 min before
slicing.
For mice prepared for soma and nuclear size analysis (6–
21 months), the PBS was followed by 10 ml of 4% PFA pH 6.5,
(5 ml/min) and 20 ml of 0.1 M borate buﬀered 4% PFA, pH
11 at a rate of 2 ml/min. After craniotomy, the brain was sub-
merged in 4% PFA, pH 11, for 2 h at RT. The brain was then
immersed in 30% sucrose in PBS and 0.01% sodium azide at 4◦C
for ∼48 h.
Brains were embedded in agar and sliced coronally on a
Vibratome Series 1000. The primary motor cortex was identi-
ﬁed by the ﬁrst appearance of the corpus callosum anteriorly and
by the joining of the anterior commissure posteriorly (∼2 mm).
Brains prepared for single cell microinjections were sliced into
∼10 200 µm-thick sections and then placed in 24-well plates
ﬁlled with PBS and 0.01% sodium azide for storage at 4◦C. Brains
TABLE 1 | Phenotype severity scale for the Jaenisch Rett syndrome mouse model (deletion of exon 3 of Mecp2).
Parameter Severity
Tremors: observed while standing
on the palm
No tremor (0) Intermittent mild tremor (1) Continuous tremor or intermittent
violent tremor (2)
Hind-clasping: observed when
suspended by holding the base of
the tail
Legs splay outwards (0) Legs are drawn inwards
slightly (1)
Legs are drawn inwards
but do not touch (2)
Legs are drawn inward and touch each
other and the body tightly (3)
Dishevelled fur Clean and shiny coat (0) Coat dull/ungroomed (1) Piloerection, dull coat/ungroomed (2)
Activity level: observed when
placed on the bench
WT activity level (0) Slower pace than WT but
still active (1)
Still for periods, but can
move slowly (2)
No spontaneous movements (3)
Breathing problems Normal breathing (0) Short periods of rapid breathing or apnea (1) Irregular breathing, gasping or
panting (2)
Hunched WT rounded posture (0) Slightly hunched (1) Hunched posture (2)
Adapted from (Guy et al., 2007).
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prepared for soma and nuclear size analysis were sliced into
50 µm-thick sections and placed in 24-well plates ﬁlled with 30%
sucrose in PBS and 0.01% sodium azide for storage at 4◦C prior
to mounting.
For microinjection, the slices were placed in a PBS bath.
The cells were visualized using a custom-made epiﬂuorescence
microscope equipped with an Olympus UPlanFl 4X/0.13 NA
lens and an Olympus LUMPlanFl 40X/0.8 NA water immer-
sion lens. Borosilicate glass pipettes (O.D. 1.5 mm ID 0.86 mm;
Sutter Instruments) were prepared with a resistance of 5–10 M
when ﬁlled with 120 mM KCl (∼0.5 µm tip opening) using
a micropipette puller (Sutter Instruments P-87). Pipettes were
backﬁlled by dipping in a solution of 3 mM Alexa Fluor 594
hydrazide dye (Invitrogen). Dye ﬂuorescence was excited using
a bandpass ﬁlter (HQ550/100, Chroma Optical) and visualized
through a 624/40 ﬁlter (Semrock BrightlineTM) using an ana-
log CCD camera connected to a TV monitor. Cells in Layer
V were targeted for ﬁlling by locating the YFP+ cells, which
were faintly visible using the above ﬁlter combination (Figure 1).
Individual neurons were targeted using transillumination and the
contrast enhancement of the monitor. Cells were impaled and
iontophoretically ﬁlled with dye using 3 ms square wave, 3 µA
current pulses repeated at 0.5 Hz for 5–10 min delivered from a
digital stimulator (Neuro Data PG4000) through an isolated cur-
rent source (NeuroData SIU90). Neurons were ﬁlled in a sparse
distribution along the slice (5–10 cells/hemisphere) to ensure that
dendrites did not overlap (Figure 1). Instances in which tissue
adhered to the pipette upon tip withdrawal were judged to be a
result of poor ﬁxation, typically resulting in dye diﬀusion out of
the cell and/or removal of the nucleus. In these cases the cell was
not used for further analysis. Once several cells were ﬁlled, the
slice was post-ﬁxed in 4% PFA pH 11 for 10 min at room temper-
ature and stored in PBS with 0.01% sodium azide at 4◦C prior to
measurement.
Immunohistochemistry and Counterstaining
All immunohistochemistry incubation steps were performed on
ﬂoating slices at room temperature, on a shaker in the dark, with
three PBS washes between each step and 0.01% sodium azide
added for overnight incubations. All slices were permeabilized
with 1% Triton X-100 in PBS for 2 h.
FIGURE 1 | Single cells microinjected with Alexa Fluor 594 dye.
Neurons selected for filling were distributed across brain slices to maximize
the total number of visible cells per slice while preventing overlap of dendrites.
Scale bar = 100 µm.
Brain slices containing dye ﬁlled neurons were immunohisto-
chemically labeled to detect the genotype of individual neurons
(Figure 2). Slices were blocked with 5% normal goat serum
in PBS overnight, then incubated overnight with monoclonal
mouse anti-N terminal MeCP2 (Sigma 4B6) and monoclonal
chicken anti-C terminal MeCP2 (Millipore ABE171) primary
antibodies prepared at 0.2 µg/ml in 1% normal goat serum
and PBS. Primary antibodies were detected with goat anti-
mouse conjugated to Alexa Fluor 647 (Invitrogen) and goat
anti-chicken conjugated to Alexa Fluor 488 (Invitrogen) sec-
ondary antibodies (4 µg/ml) prepared in 1% normal goat serum
in PBS and incubated overnight. Slices were counterstained
for 10 min with 30 nM 4′,6-diamidino-2-phenylindole (DAPI)
in PBS.
Brain slices prepared for soma and nuclear size analy-
sis (Figure 2) were incubated overnight with monoclonal
chicken anti-C terminal MeCP2 (Millipore ABE171) pri-
mary antibody prepared at 0.2 µg/ml in PBS. The pri-
mary antibody was detected using goat anti-chicken secondary
antibodies conjugated to Alexa Fluor 555 (Invitrogen) pre-
pared at 4 µg/ml in PBS and incubated overnight. Slices
were counterstained with DAPI (30 nM) and the deep-
red ﬂuorescent Nissl stain Neurotrace 640/660 (Invitrogen)
overnight.
Lipofuscin Reduction
Broad-spectrum lipofuscin autoﬂuorescence in older mice inter-
feres with the visibility and quantiﬁcation of neuronal den-
drites (Figure 2). After completing immunohistochemistry
and counterstaining protocols, lipofuscin autoﬂuorescence was
quenched by treating cortical slices with 5 mM CuSO4
in 50 mM ammonium acetate for 10 min (Schnell et al.,
1999).
Fluorescence Microscopy
Slices were mounted on poly-l-lysine coated slides and cov-
ered with #1.5 coverslips using Immu-mount medium (Thermo
Scientiﬁc). All images for quantiﬁcation of dendrite structure
were obtained using an Olympus UPlanFLN 40X/1.3 NA oil
objective. Confocal stacks of single cells microinjected with
Alexa Fluor 594 hydrazide were acquired using a 543 nm laser,
610/100 emission ﬁlter, 640 × 640 pixel resolution, 0.5 µm steps,
40 µs/pixel dwell, and high laser power. The high voltage, gain,
and oﬀset were modiﬁed during imaging to optimize visibil-
ity of the dendrites and ensure that the end of each dendrite
was clearly ascertained. Any dendrites that projected beyond the
ﬁeld of view were captured in an additional adjacent stack. In
order to genotype individual neurons, a separate confocal stack
centered on the cell body was acquired at 6X zoom with addi-
tional channels for detection of the C-terminal (488 nm laser,
515/20 emission) and N-terminal (635 nm laser, 705/100 emis-
sion) MeCP2 antibodies. Brain slices prepared for soma and
nuclear size analysis were viewed on an Olympus IX70 inverted
epiﬂuorescence microscope. 5–20 images per animal were cap-
tured with a Retiga 2000R digital CCD camera (QImaging,
Surrey, BC, Canada) with an additional 1.6X post objective
magniﬁcation.
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FIGURE 2 | Immunohistochemical genotyping to identify dye-filled,
nuclear-, or cytoplasm-counterstained neurons for morphological
comparisons. (A) C-terminal MeCP2 antibody staining appears punctate in
MeCP2+ neurons and diffuse in MeCP2− neurons (arrows). (B) N-terminal
MeCP2 staining appears punctate in MeCP2+ neurons, and is absent in
MeCP2- neurons (arrows). (C) Alexa Fluor 594 (AF594) iontophoretically
injected into lightly fixed neurons fills the cell body and dendrites.
(D) Composite image of A–C. Pink = MeCP2+, red = MeCP2−; in
composite image the AF594 fluorescence obscures the punctate nuclear
MeCP2+ staining that can be seen in panels A and B which show filled
neuron is wild-type). Scale bar = 20 µm. (E) DAPI nuclear labeling reveals
which cells are in the in focal plane and delineates the boundary of
nucleus. (F) Punctate (arrowhead) or diffuse (arrow) staining of the
C-terminal MeCP2 antibody differentiates MeCP2+ and MeCP2− cells,
respectively. (G) The cytoplasm of neurons is labeled with Neurotrace Nissl
body stain. (H) A composite image reveals the genotype of each neuron.
MeCP2- cells appear blue/green because the red C-terminal MeCP2 stain
is faint and diffuse. Scale bar = 20 µm. (I) Granular lipofuscin
autofluorescence is faint in a brain slice at 9 months of age. (J) Lipofuscin
accumulates in brain tissue over time. In an 18-months old animal strong
autofluorescence makes the visualization and quantification of fluorescent
dyes difficult. (K) Treatment of slices with 5 mM CuSO4 in 50 mM
ammonium acetate considerably reduces lipofuscin autofluorescence without
affecting AF594 staining. Scale bar = 50 µm.
XCI Ratios and Soma/Nuclear Size
Measurements
Wideﬁeld ﬂuorescence images were obtained from slices of tis-
sue from 30 Mecp2+/− animals in one experiment and 11
Mecp2+/− and 10 Mecp2+/+ animals in a second experiment
(30–80 cells/animal). Images were obtained using a UPlanFLN
40X 1.30 NA oil immersion objective (Olympus) focused at 2–3
separate planes, between 10 and 25 µm below the surface, each
separated by ∼5 µm. Inclusion criteria for measured cells at each
focus position were: (1) the DAPI-stained nucleus must be in
sharp focus in the focal plane (2) the Neurotrace-stained soma
must not be occluded by overlying cells, and (3) the genotype
must be clearly identiﬁable using C-terminal MeCP2 antibody
staining. MeCP2+ neurons were counted if punctate staining
of the C-terminal antibody (colocalized with the DAPI stain-
ing) was visible. MeCP2− neurons were counted if DAPI and
diﬀuse C-terminal antibody staining were visible. Outlines of
somata (Neurotrace) and nuclei (DAPI) were manually traced
at 8X image magniﬁcation using ImageJ (Abràmoﬀ et al., 2004).
All in-focus neurons that were completely within the ﬁeld of
view and met the above criteria were measured and since X-
inactivation is skewed toward wild-type more MeCP2+ than
MeCP2− neurons were measured.
Neuronal Reconstruction and Morphological
Analysis
Eighty two MeCP2 WT neurons, 98 MeCP2+ and 59 MeCP2−
neurons were ﬁlled and reconstructed (ﬁve animals per genotype,
16–31 cells per animal). In order to minimize variation associated
with poor ﬁlls or chopped dendrites neurons were excluded if:
(1) the genotype could not be determined (2) less than three pri-
mary dendrites were intact (3) more than half of the total primary
dendrites on the cell body were chopped oﬀ by the slicing (4)
tips of the dendrites were not visible (5) an apical dendrite of at
least 75 micrometers length was not visible. If dendrites extended
beyond the edge of one ﬁeld of view additional image stacks
were obtained and tiled in 3D using the Volume Integration
and Alignment System (VIAS; Rodriguez et al., 2003). ImageJ
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was used to adjust the image brightness/contrast and images
were saved as 8-bit tiﬀs. 3D neuronal reconstructions were gen-
erated in Neuronstudio (Wearne et al., 2005) using a Cintiq
21q tablet. Neuron tracings were exported in SWC ﬁle format,
for compatibility with standard morphometric software tools.
Multiple morphological parameters were extracted using the free-
ware applications Neuronstudio, Simple Neurite Tracer (Longair
et al., 2011), and L-Measure (Scorcioni et al., 2008). The morpho-
logical parameters chosen for analysis in this study are listed in
Table 2 and further described in Figure 3 adapted from proce-
dures and conventions described by Scorcioni et al. (2008) and
Costa et al. (2010).
Statistical Analysis
Statistical analyses were conducted using Prism software
(GraphPadTM). Data are presented as mean ± standard error of
the mean (SEM). All parameters assessed across Sholl radii (Sholl,
1953) or branch orders were analyzed using two-way repeated
measures ANOVA with multiple comparisons made using the
Bonferroni post-test. Primary dendrite number was assessed
using a one-way ANOVA and multiple comparisons were made
using the Bonferroni post-test. Direct comparisons of soma and
nuclear areas between animals of diﬀerent genotypes were per-
formed using the non-parametric two-tailed Mann–Whitney U
test. Comparisons between cells of diﬀerent genotypes within the
same animal were performed using the paired Wilcoxon signed
rank test. Linear regressions were used to compare the slopes and
y-intercepts of soma and nuclear area data obtained across ages
and XCI ratios. Non-linear regressions were ﬁt to the frequency
distributions of soma and nuclear areas and the best-ﬁt values
were compared. p-values of≤0.05 were considered signiﬁcant for
all statistical tests.
TABLE 2 | Morphological parameters analyzed from 3D neuronal
reconstructions.
Program Parameter/description
Neuronstudio Sholl length (µm) – Total length of all branches per 10 µm Sholl
radius
Cumulative Sholl length (µm) – Cumulative length of all branches
per 10 µm Sholl radius
Sholl branch points – Total number of branch points per 10 µm
Sholl radius
Branch length/branch order – Average branch length per branch
order
L-Measure Total number of primary dendrites stemming from the soma
Total length of all branches per branch order
Number of branch points per branch order
Number of branches per branch order
Number of tips per branch order
Maximum radial distance (µm) – Euclidean distance between the
soma and the farthest compartment reached by a dendrite
Maximum branch order per 10 µm Sholl radius
Contraction per branch order – ratio between the Euclidean
distance and branch path distance calculated per branch order
Partition asymmetry – where T1 and T2 are the number of tips of
each daughter tree. Computed at every branch point and plotted
as function of branch order
FIGURE 3 | Diagram of morphometric measurements. A primary dendrite
is any dendrite originating from the cell body. A branch point occurs when the
original dendrite bifurcates into two or more daughter trees. A centrifugal
labeling scheme was used for assigning branch order, where the lowest order
is given to the primary dendrites and increases when a branch point is
reached. Maximum branch order is the maximum value reached by any
primary tree on a given cell. A branch is a length of dendrite between the
soma and a branch point, between two branch points, or between a branch
point and a tip. A tip is the termination of any branch. Sholl radii are concentric
spheres originating from the centroid of the soma and increasing at 10 µm
intervals. Maximum radial distance is the maximum Sholl radius reached by
any single dendrite per cell. Partition asymmetry is calculated at each branch
point as | T1–T2| /(T1 + T2-2) where T1 and T2 are the number of tips of the
two daughter trees, with values of one and zero indicating asymmetrical and
symmetrical partitioning respectively. Contraction is calculated for each
branch as a ratio between the Euclidean distance and the distance along the
branch path. A value of one indicates perfectly straight dendrites, while lower
values indicate increasing levels of tortuosity or winding of the dendrites.
Derived in part from (Costa et al., 2010).
Results
Sholl Analysis of Basal Dendritic Arbor of
Motor Cortical Layer V Pyramidal Neurons
of MeCP2 WT, MeCP2+, and MeCP2−
Neuronal Genotypes
Sholl analysis (Sholl, 1953) was used to determine how a muta-
tion in Mecp2 aﬀects the dendritic morphology of MeCP2+ and
MeCP2− neurons compared to MeCP2 WT neurons. The total
dendritic length per 10 µm Sholl radius was reduced in MeCP2-
neurons at distances of 70–130 µm from the soma compared
to both MeCP2 WT and MeCP2+ neurons (two-way repeated
measures ANOVA and Bonferroni post-tests, F(62,372) = 2.33,
p < 0.0001; Figure 4A). MeCP2 WT and MeCP2+ neurons
are not diﬀerent at any Sholl radius (p > 0.05). The slopes of
the MeCP2+ and MeCP2 WT curves diverge from that of the
MeCP2− curve between 30 and 60 µm from the cell body, and
run parallel at greater distances, indicating that diﬀerences in
length between the genotypes are initiated in this region and
maintained into the distal regions.
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FIGURE 4 | Total dendritic length of MeCP2- neurons is reduced.
(A) MeCP− neurons have decreased dendritic length at distances of
70–130 µm from the soma compared to both MeCP2 WT and MeCP2+
neurons. The region between the dashed lines indicates where the slopes of
MeCP2− and MeCP2+ cells deviate. (B) MeCP2− neuron total basal
dendritic length is 15% less (275 µm) compared to both MeCP2 WT and
MeCP2+ neurons. Dashed lines indicate the average maximum radial
distance reached for each genotype. No significant difference was found
between the genotypes in this measure. ∗p < 0.05, ∗∗p < 0.01, and
∗∗∗p < 0.001. For Figures 4–6, 82 MeCP2 WT neurons, 98 MeCP2+ and 59
MeCP2− neurons were filled and reconstructed (five animals per genotype,
16–31 cells per animal).
To quantify the total diﬀerences in dendritic length observed
in Figure 4A, cumulative dendritic length was calculated at
each successive 10 µm Sholl radius (Figure 4B). MeCP2−
neurons have a signiﬁcant reduction (15% or 275 µm) in
cumulative dendritic length compared to both other geno-
types, while MeCP2 WT and MeCP2+ are not signiﬁ-
cantly diﬀerent [MeCP2− = 1600.6 ± 66.2 µm, MeCP2
WT = 1898.5 ± 77.6 µm, MeCP2+ = 1873.9 ± 66.5 µm;
two-way repeated measures ANOVA and Bonferroni post-tests,
F(44,264) = 4.68, p < 0.0001]. The maximum radial distance was
not diﬀerent between the genotypes [MeCP2−= 149.7± 4.3µm,
MeCP2WT= 159.7± 5.9µm,MeCP2+= 155.5± 6.2µm; one-
way ANOVA, F(2,12) = 0.83, p = 0.5] suggesting that although
MeCP2− neurons have less length than MeCP2+ neurons, the
reach of their dendritic arbor is not signiﬁcantly lessened.
Branch path distances at successive 10 µm Sholl radii were
compared across genotypes (Figure 5A) to determine whether
the cumulative length deﬁciency of MeCP2− neurons is due
to a decreased tortuosity of the branches. No diﬀerences were
found between the genotypes at any Sholl radii [two-way repeated
measures ANOVA and Bonferroni post-tests, F(30,180) = 1.05,
p = 0.4], indicating that the reduction in MeCP2- dendritic
length is not due to straighter branches.
The number of primary dendrites was compared (Figure 5B)
across neuronal genotypes to determine if the diﬀerences in
length of MeCP2- neurons (Figure 4B) could be accounted for
by their having a diﬀerent number of primary branches. There
was no diﬀerence in the total number of primary dendrites across
all genotypes [one-way ANOVA, F(2,12) = 0.15, p = 0.9].
Examining the cumulative number of branch points at each
successive 10µmSholl radius (Figure 5C) revealed thatMeCP2−
neurons have an average of three (17%) fewer total branch points
than both other genotypes [MeCP2− = 13.7 ± 0.7, MeCP2
WT = 16.5 ± 0.4, MeCP2+ = 16.2 ± 0.8; t(24) = 3.51, p < 0.01,
two-way repeated measures ANOVA and Bonferroni post-tests,
F(24,144) = 8.58, p< 0.0001]. The slopes of the lines diﬀer between
30 and 60 µm from the soma, suggesting that MeCP2− neurons
have fewer branch points in this region.
The reduced number of branch points in MecP2− cells could
be the result of either fewer simple primary trees (low maxi-
mum branch order), fewer complex ones (high maximum branch
order), or both. In order to determine which was the case, the
maximum branch order reached per cell at each successive 10µm
Sholl radii was compared across the genotypes (Figure 5D).
At 60 µm (MeCP2− = 4 ± 0.20, MeCP2 WT = 5 ± 0.3,
MeCP2+ = 5 ± 0.2; t(24) = 3.43, p < 0.05) and 110 µm
(MeCP2− = 4± 0.2, MeCP2WT= 5± 0.1, MeCP2+ = 5± 0.3;
t(24) = 3.43, p < 0.05) from the soma MeCP2− neurons have a
lower maximum branch order compared to both other genotypes
[two-way repeated measures ANOVA and Bonferroni post-tests,
F(2,12) = 1.38, p < 0.0001]. Since MeCP2+ cells have a relatively
high maximum branch order (ﬁve) at these distances, this sug-
gests thatMeCP2− cells have fewer overall branch points because
they have fewer complex branches.
Branch Order Analysis of MeCP2 WT,
MeCP2+, and MeCP2− Neuronal Genotypes
Branch order analysis was used to determine how a reduction
in total branch point number aﬀects the detailed branch struc-
ture of Mecp2− neurons (Figure 6). The number of branch
points within each branch order was ﬁrst compared across the
neuronal genotypes (Figure 6B). MeCP2− neurons have fewer
branch points at the second [MeCP2− = 4.6 ± 0.3, MeCP2
WT = 5.3 ± 0.1, MeCP2+ = 5.1 ± 0.4; t(16) = 3.05, p < 0.05]
and third [MeCP2− = 2.7 ± 0.2, MeCP2 WT = 3.7 ± 0.3,
MeCP2+ = 3.2 ± 0.2; t(16) = 4.25, p < 0.001] branch orders
compared to both other genotypes [two-way repeated measures
ANOVA and Bonferroni post-tests, F(16,96) = 1.69, p = 0.03].
MeCP2− neurons therefore have, on average, one less branch
point at each of the second and third branch orders. No statis-
tically signiﬁcant diﬀerences were found between MeCP2− and
MeCP2+ cells at the ﬁrst or fourth branch orders, yet MeCP2−
cells appear to have fewer branch points here, raising the possibil-
ity that these branch orders may be aﬀected by MeCP2 mutation
as well.
Partition asymmetry was next calculated at each branch order
to assess whether branching patterns were altered in MeCP2−
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FIGURE 5 | MeCP2− neurons have a reduction in the number of total
branch points and maximum branch order across Sholl radii. (A) Basal
dendrites of all genotypes have similar path distances across Sholl radii. (B) All
genotypes have the same number of primary dendrites. (C) MeCP2− neurons
have an average of three fewer total branch points (a 17% reduction)
compared to both other genotypes. The region between the dashed lines
indicates where the MeCP2− neurons differ from MeCP2+ neurons in trend.
(D) The maximum branch order reached by MeCP2− neurons at distances of
60 and 110 µm from the soma is lower than both other genotypes. ∗p < 0.05
and ∗∗p < 0.01.
neurons (Figure 6C). No diﬀerence was found between the geno-
types across branch orders [two-way repeated measures ANOVA
and Bonferroni post-tests, F(8,48) = 2.23, p = 0.58), indicating
that MeCP2− neurons do not have more asymmetric branching
patterns than MeCP2+ cells.
The number of branches per branch order was then cal-
culated (Figure 6D) to conﬁrm that the reduced numbers of
second and third order branch points seen in MeCP2− neu-
rons also results in a reduction in the number of subsequent
branches in the third and fourth branch orders of these neu-
rons. MeCP2− neurons have 16% fewer third order branches
[∼2 branches; MeCP2− = 9.2 ± 0.7, MeCP2 WT = 11.0 ± 0.1,
MeCP2+ = 10.6 ± 0.7; t(17) = 3.59, p < 0.01] and 25% fewer
fourth order branches [∼2 branches; MeCP2− = 5.3 ± 0.3,
MeCP2 WT = 7.0 ± 0.7, MeCP2+ = 6.2 ± 0.4; t(14) = 3.46,
p < 0.01; two-way repeated measures ANOVA and Bonferroni
post-tests, F(14,84) = 1.51, p = 0.02]. These data conﬁrm that the
lesser numbers of second and third order branch points result in
a reduction in third and fourth order branches.
The total dendritic length per branch order was quanti-
ﬁed (Figure 6E) to see if the reduced number of third and
fourth order branches in MeCP2− neurons could account for
the total reduction in dendritic length observed in these cells.
MeCP2− neurons were found to have signiﬁcantly less length
in the third (17%) and fourth (27%) branch orders, as was
predicted from the reduced number of third and fourth order
branches [third order: MeCP2− = 499.8 ± 28.0 µm, MeCP2
WT = 599.5 ± 43.2 µm, MeCP2+ = 554.6 ± 50.4 µm;
t(14) = 2.93, p< 0.05; fourth order: MeCP2−= 300.3± 34.9µm,
MeCP2 WT = 414.0 ± 23.9 µm, MeCP2+ = 380.2 ± 17.4 µm;
t(14) = 3.34, p < 0.01; two-way repeated measures ANOVA and
Bonferroni post-tests, F(14,84) = 1.15, p = 0.03]. These data indi-
cate thatMeCP2− cells have 100 and 115µm less dendritic length
in the third and fourth branch orders, respectively.
Finally, the average dendritic length per branch order was
assessed (Figure 6F) to determine whether the shorter branches
observed in MeCP2− neurons could also contribute to the
reduced length observed in these cells. No diﬀerence was found
in average branch length per branch order between the genotypes
[two-way repeated measures ANOVA and Bonferroni post-tests,
F(8,48) = 0.36, p = 0.8]. This suggests that the shorter dendritic
length observed in MeCP2− neurons is not caused by their hav-
ing shorter branches than the other genotypes, but primarily from
their reduced number of third and fourth order branches.
Cell Autonomous Effects on Soma and
Nuclear Areas
The nuclear and somatic areas of MeCP2+ and MeCP2− Layer
V motor pyramidal neurons were measured in Mecp2+/− mice
(Figure 7). The mean nuclear area of MeCP2− neurons in
these experiments was 13% smaller than that of MeCP2+ neu-
rons [n = 24 animals, MeCP2− = 93.3 ± 1.4 µm2, MeCP2+
107.9 ± 1.2 µm2, t(46) = 8.04, p < 0.0001; Figure 7A]. A plot
of the entire population of individual nuclear areas [MeCP2+
n = 598 neurons, MeCP2− n = 418 neurons (Figure 7B)] shows
that the proportion of small neurons between the two genotypes
are comparable, while the proportion of neurons in the largest
size class is considerably smaller in the MeCP2− cell population
than it is in the MeCP2+ population. The mean soma area of
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FIGURE 6 | MeCP2− neurons have fewer third and fourth order
branches compared to both other genotypes. (A) Branch order diagram
depicting the increasing order values with each successive branch point from
the cell body. Symmetrical and asymmetrical branching patterns are shown
(calculated at the second order branch points) which result in partition
asymmetry values of 0 and 1, respectively. (B) MeCP2− neurons have fewer
second and third order branch points compared to both genotypes.
(C) Branching patterns in MeCP2− neurons are unaltered. (D) MeCP2−
neurons have fewer third and fourth order branches. (E) MeCP2− neurons have
reduced dendritic length in the third and fourth branch orders. (F) The average
length of MeCP2− branches per branch order does not differ from that of
MeCP2+ branches. ∗p < 0.05, ∗∗p < 0.01 and ∗∗∗p < 0.001.
MeCP2− neurons is 15% smaller than MeCP2+ [n = 24 ani-
mals, MeCP2− = 143.3 ± 2.5 µm2, MeCP2+ 169.2 ± 1.9 µm2,
t(46) = 8.25, p < 0.0001; Figure 7C]. A graph of individual soma
areas (MeCP2+ n = 598 neurons, MeCP2− n = 418 neurons,
Figure 7D) shows that smallest somata of MeCP2− (79.8 µm2)
and MeCP2+ (76.3 µm2) genotypes are comparable, while the
largest quartile of MeCP2− somata is considerably smaller than
the largest quartile of MeCP2+ somata. Frequency distributions
of the areas of nuclei (Figure 7E) and somata (Figure 7F) show
that the distribution of MeCP2− neuron sizes is signiﬁcantly
shifted toward the smaller size classes compared to MeCP2+
neurons [nuclear area t(3,21) = 23.66, p < 0.0001, soma area
t(3,36) = 27.57, p < 0.0001]. To assess whether the soma or
nuclear areas in MeCP2− neurons were reduced disproportion-
ally in relation to the each other, MeCP2+ and MeCP2− soma
areas were plotted against their respective nuclear areas from
within the same population (Figure 7G). The resulting slopes
of MeCP2− and MeCP2+ populations were not signiﬁcantly
diﬀerent [F(1,1012) = 1.08, p = 0.3] showing that while MeCP2−
nuclei and soma are smaller in area than their MeCP2+ coun-
terparts, the proportion of soma and nuclear areas are similar in
both genotypes.
Symptom Severity of Mecp2+/− Mice Across
Age and XCI Ratios
To determine the interaction between age, cell phenotype, and
XCI ratios, animals were scored for their phenotype severity at
their time of sacriﬁce for immunohistochemical staining (from
5 to 22 months of age). Within the cohort of mice selected for
our study the phenotype severity was highly variable, with some
mice dying prematurely as young as 2 months of age (i.e., before
they could be used for experiments), and others surviving into old
age (22 months) with only mild symptoms (Figure 8). Increasing
age did not correlate with increased phenotype severity (p = 0.2,
R2 = 0.038). To determine whether symptom levels vary accord-
ing to XCI ratio, XCI ratios were analyzed by immunohisto-
chemistry and compared against phenotype severity. It was found
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FIGURE 7 | MeCP2− neurons have smaller somata and nuclei than
MeCP2+ neurons. MeCP2− nuclei (A) and somata (C) are on average
13 and 15% smaller than MeCP2+ nuclei and somata, respectively
(n = 24 animals). The population of MeCP2− nuclei (B) and somata
(D) have fewer large nuclei and somata compared to MeCP2+ (MeCP2+
n = 598 cells and MeCP2− n = 418 cells). Frequency distributions of
nuclear (E) and soma (F) areas are significantly different between the
genotypes (p < 0.0001, nuclear area MeCP2+ R2 = 0.96 and MeCP2−
R2 = 0.98; Soma area MeCP2+ R2 = 0.93 and MeCP2− R2 = 0.94).
(G) Soma area is a predictor of nuclear area in both genotypes. Slopes
are equal between the genotypes (p = 0.30, MeCP2+ R2 = 0.79 and
MeCP2− R2 = 0.78). ∗∗∗p < 0.001.
that XCI ratios were also not correlated with phenotype sever-
ity (Figure 8; p = 0.66, R2 = 0.0062). Surprisingly, mice with
a highly skewed XCI ratio favoring expression of the wild-type
chromosome (10% MeCP2−:90% MeCP2+) did not have less
severe symptoms than mice with a more balanced XCI ratio (50%
MeCP2−:50%MeCP2+).
Effect of Age on Soma and Nuclear areas
Age did not aﬀect nuclear area [MeCP2+ F(1,22) = 0.0089,
p = 0.92, MeCP2− F(1,22) = 0.012, p = 0.61] or somatic area
[MeCP2+ F(1,22) = 0.34, p = 0.57, MeCP− F(1,22) = 0.069,
p = 0.79] for either genotype (Figure 9). The linear regres-
sion slopes for MeCP2+ and MeCP2− cells are not signiﬁcantly
diﬀerent in either nuclear [F(1,44) = 0.21, p = 0.65] or soma
[F(1,44) = 0.023, p = 0.88] areas, plotted across age from 5 to
22 months.
Effect of XCI Ratios on Soma and Nuclear
Areas
To determine if XCI ratios have an eﬀect on soma or nuclear
sizes of MeCP2+ and MeCP2− neurons, somatic and nuclear
areas were plotted against the proportion of MeCP2− neurons
in the brain (Figure 10). The linear regression slope of MeCP2−
nuclear area was signiﬁcantly diﬀerent from that of MeCP2+
nuclear area [F(1,44) = 4.26, p = 0.045; Figure 10A]. This indi-
cates that as the proportion of wild-type neurons in the brain
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FIGURE 8 | Age, phenotype severity and XCI ratios are not correlated
in Mecp2+/− mice. Increasing age is not a predictor of phenotype severity of
Mecp2+/− mice. Aged Mecp2+/− animals are not more likely to have highly
skewed XCI ratios (10–30% mutant neurons, red circles) and XCI ratios do not
predict phenotype severity at any age. Premature death (x’s) occurred across
both young and old age groups. A premature death is defined as any animal
that died spontaneously (not sacrificed for experiments), therefore XCI ratios
were unavailable.
increases, the nuclear area of MeCP2+ neurons increases, while
the area of MeCP2− nuclei decreases. The slope of the MeCP2−
soma area does not diﬀer statistically from that of the MeCP2+
soma area [F(1,44) = 3.41, p = 0.07; Figure 10B], however, the
trend of diverging slopes is apparent.
To minimize inter-animal diﬀerences (i.e., diﬀerences associ-
ated with tissue preparation and ﬁxation), MeCP2− areas were
normalized to MeCP2+ areas in each slice and plotted across
the proportion of MeCP2− neurons in the brain (Figure 10C).
The normalized nuclear area of MeCP2− neurons was pos-
itively correlated to the proportion of MeCP2− neurons in
the brain [F(1,22) = 18.14, p = 0.0003]. The normalized soma
area of MeCP2− neurons was also positively correlated to the
proportion of MeCP2− neurons in the brain [F(1,22) = 8.08,
p= 0.0095]. These data suggest that animals with a highly skewed
XCI ratio, favoring expression of the wild-type allele (<30%
MeCP2−/>70% MeCP2+) have the most severe MeCP2− neu-
ronal phenotype (17–22% smaller than MeCP2+). Animals with
a balanced XCI ratio (∼50% MeCP2−/50% MeCP2+) have
MeCP2- neurons with a comparatively less severe neuronal phe-
notype (11–17% smaller than MeCP2+).
Soma and Nuclear Size of MeCP2 WT
Versus MeCP2+ Neurons
For the study summarized in Figures 7, 9, and 10, we did
not have a comparison group of wild-type littermates, so
it was not possible to test whether, MeCP2+ neurons were
comparable to MeCP2 WT neurons, with respect to soma
and nuclear size. Since a number of sources of error can
potentially aﬀect cell size, such as variation in cell shrink-
age during ﬁxation, we analyzed an entirely new group of
mice comprising heterozygous females and their wild-type
female littermates. As expected, comparison of MeCP2+ to
MeCP2− soma and nuclear sizes in this new cohort of ani-
mals revealed a diﬀerence for the group mean data [Figure 11;
mean soma diﬀerence 8.8 µm2, p < 0.0020, n = 11 ani-
mals; mean nuclear diﬀerence 4.1 µm2, p < 0.005). Within
animal paired sample comparisons were eﬀective to increase
statistical signiﬁcance and within animal soma and nuclear
sizes were strongly correlated between genotypes (MeCP2+
regressed against MeCP2−, R2 = 0.97, p < 0.0001, nuclear
R2 = 0.90 p < 0.0001), indicating that inter-animal variabil-
ity contributes a substantial amount of variance to the group
means.
MeCP2+ neurons in the heterozygous brain were smaller,
on average, than MeCP2 WT neurons [mean soma diﬀerence
15.4 µm2, p < 0.032; nucleus 10.0 µm2, p < 0.038, n = 10
WT, n = 11 MeCP2+). Pairwise comparisons based on lit-
termate status (siblings) or day of tissue preparation did not
measurably improve the statistical discrimination of the diﬀer-
ence between MeCP2 WT and MeCP2+ neurons. This conﬁrms
that the main source of variance in these experiments is intrinsic
inter-animal variability in cell size, rather than variance in tissue
preparation. When the overall cell size distribution is examined
(Figure 11B), the tendency for theMeCP2−population to appear
shifted toward smaller sizes when compared to the population
of MeCP2+ cells, is once again apparent. Interestingly, the pop-
ulation of MeCP2+ cells also seems shifted toward small size
when compared to the population of cells in Mecp2+/+ animals.
Once again, the smallest cells in each population are similar in
size.
FIGURE 9 | Age does not affect nuclear and soma areas. (A) Nuclear area in MeCP2+ and MeCP2− neurons is not altered across age (MeCP2+
R2 = 0.00040 and MeCP2− R2 = 0.012). (B) Soma area in both genotypes is not affected by age (MeCP2+ R2 = 0.015 and MeCP2− R2 = 0.0031).
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FIGURE 10 | Nuclear and soma areas are correlated with XCI ratios.
(A) Nuclear areas of MeCP2+ and MeCP2− neurons diverge as XCI ratios
become more skewed in favor of MeCP2+ expression (right to left). Slopes are
significantly different between the genotypes (p = 0.04, MeCP2+ R2 = 0.069
and MeCP2− R2 = 0.11). (B) Soma areas of MeCP2+ and MeCP2− neurons
appear to diverge as the proportion of MeCP2− neurons in the brain decreases
(right to left). Slopes are not significantly different between the two genotypes
(p = 0.07, MeCP2+ R2 = 0.13 and MeCP2− R2 = 0.041). (C) MeCP2- soma
and nuclear areas were normalized to paired MeCP2+ values from the same
animal. MeCP2− nuclei and somata in brains with XCI ratios highly skewed
toward wild-type (>70%% MeCP2+) are significantly smaller than MeCP2−
nuclei and somata in brains with more balanced XCI ratios (∼50% MeCP2+).
Slopes are significantly non-zero (nuclear area p = 0.0003 R2 = 0.45, soma
area p = 0.0095, R2 = 0.29).
Discussion
MeCP2− Neurons have Reduced total
Dendritic Length and Fewer Third and
Fourth Order Branches
We ﬁnd that MeCP2− layer V pyramidal neurons in heterozy-
gous brains have shorter basal dendritic length, due to their hav-
ing fewer third and fourth order branches compared to MeCP2+
neurons (see Figure 12 for summary). This supports previous
research in Mecp2tm1.1Jae male mice that also found a reduc-
tion in the number of higher order branches in layer V cells
(Stuss et al., 2012). Within the basal dendritic compartment, the
principal diﬀerence between neurons containing mutant MeCP2
protein compared to those expressing the wild-type allele in both
Mecp2+/− and Mecp2+/+ animals is a selective reduction in the
number of third and fourth order branches. The similar pattern
of reduced basal dendritic morphology of Layer V pyramidal
neurons for both MeCP2− neurons in Mecp2+/− females and
male Mecp2−/y mice indicates that MeCP2 acts predominantly
in a cell-autonomous manner to aﬀect the dendritic morphol-
ogy of this compartment of MeCP2− neurons. These results are
consistent with other studies that found that callosal projection
neurons from Mecp2−/y mice transplanted into either wild-type
orMecp2−/y brains had primarily cell autonomous reductions in
dendritic morphology (Kishi and Macklis, 2009).
MeCP2+ neurons were indistinguishable from MeCP2 WT
neurons in Mecp2+/+ animals with respect to cumulative den-
dritic length, number of branch points, and maximum branch
order versus distance from the soma. Therefore, we ﬁnd that the
basic neuronal morphology of Layer V basal dendrites is primar-
ily aﬀected by MeCP2 in a cell-autonomous manner. However,
examination of some branch order analyses (Figures 6B,D,E)
suggest MeCP2+ neurons have properties intermediate to those
of MeCP2 WT and MeCP2−. Therefore, while cell-autonomous
(genotype-speciﬁc) eﬀects appear to dominate branch structure,
additional non-cell-autonomous eﬀects may also be inﬂuencing
branching. An inherent diﬃculty with analysis of basal dendrite
branching in layer V cortical neurons is the large variation in den-
dritic structure inherent to this neuronal population (Tsiola et al.,
2003). A large number of neurons must therefore be sampled
to obtain a representation of the “average” layer V pyrami-
dal neuron making detailed comparisons between the dendritic
arbors of neurons expressing wild-type MeCP2 inMecp2+/+ and
Mecp2+/− animals a challenging task.
Our analysis of 35 heterozygous mice did not reveal a cor-
relation between XCI ratios in the primary motor cortex and
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FIGURE 11 | Soma and nuclear size comparison between wild-type and
heterozygous females. (A,C) MeCP2 WT Layer V neurons (wild-type) are
larger than MeCP2+ neurons in heterozygous mice, which suggests a
non-cell-autonomous effect of MeCP2 deficiency (MeCP2 WT, n = 10 animals;
MeCP2+, n = 11; MeCP2− n = 11). (B,D) MeCP2+ and MeCP2− neuronal
populations in heterozygous brains each have a smaller proportion of large cells
than the population of MeCP2 WT cells. The MeCP2− cell population also has
fewer large cells than the MeCP2+ population in heterozygous brains. (total
cells assessed MeCP2 WT, n = 761 neurons; MeCP2+, n = 482; MeCP2−
n = 502). *p < 0.05 and **p < 0.01.
FIGURE 12 | Diagram of average MeCP2 WT, MeCP2+, and MeCP2−
layer V pyramidal neurons. The average MeCP2 WT and MeCP2+ neurons
are equivalent across all morphological parameters investigated except soma
and nuclear size. The average MeCP2− neuron (right) has approximately 15%
less total dendritic length compared to either of the other genotypes. The
average MeCP2− neuron has three fewer branch points, leading to a reduced
number of higher order branches. The maximum branch order of MeCP2−
neurons is also reduced. MeCP2- neurons have the same average maximum
radial distance as both MeCP2 WT and MeCP2+ neurons. Somata of MeCP2−
neurons are smaller than MeCP2+ especially in highly skewed XCI animals.
Branch order: first = red, second = orange, third = green, fourth = blue,
fifth = purple, sixth = black. Radii are 20 µm.
the severity of behavioral phenotype, although previous research
has suggested that the severity of the RTT phenotype may be
inﬂuenced by the proportion of Mecp2− neurons in the brain
(Sirianni et al., 1998; Amir and Zoghbi, 2000; Plenge et al., 2002;
Miltenberger-Miltenyi and Laccone, 2003; Young and Zoghbi,
2004; Weaving et al., 2005; Archer et al., 2007). We acknowledge
that our phenotype severity was scored using gross behavioral
tests, rather than more extensive testing which has been shown to
reveal subtle abnormalities even in young female mice (Samaco
et al., 2012), which do not ordinarily show obvious symptoms.
Additionally, XCI ratios were determined using immunohisto-
chemical analysis of MeCP2+ and MeCP2− neurons in the
motor cortex of the brain, whereas other studies use blood or
peripheral tissue to determine the XCI ratio, which has been
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FIGURE 13 | Proposed model for cell non-autonomous effects of
balanced and skewed XCI ratios. (A) Cell- autonomous effects on the
morphology of MeCP2− containing neurons, including reductions in
dendritic length and fewer branch points compared to MeCP2+ cells, may
render them less competitive for synaptic connections in the heterozygous
brain. (B) A balanced XCI ratio may provide MeCP2− neurons more
opportunity to make connections, as there are fewer large MeCP2+
neurons to compete with. This may reduce the severity of the
morphological phenotype of MeCP2− cells. (C) A skewed XCI ratio
favoring MeCP2+ neurons provides for a more competitive environment for
synaptic connections. MeCP2− neurons are less able to compete and
therefore have a more severe morphological phenotype.
reported to not necessarily correlate with the XCI in the brain
(Gale et al., 1994; Sharp et al., 2000; Young and Zoghbi, 2004).
Furthermore, although immunohistochemical determination of
XCI may be more accurate, we limited our analysis to layer V
pyramidal neurons, which appear to be particularly subject to
wide ﬂuctuations in the pattern of XCI inactivation (Wu et al.,
2014).
Soma and Nuclear Size of MeCP2− Neurons
are Reduced in the Mecp2+/− Brain
Analysis of soma and nuclear size revealed that the average
MeCP2− soma/nucleus is smaller than that of the average
MeCP2+ neuron, consistent with previous studies comparing
male Mecp2−/y to Mecp2+/y mice (Kishi and Macklis, 2004;
Fukuda et al., 2005).When the distribution of individual cell sizes
from all animals are pooled, the MeCP2− population appears
to primarily lack neurons comparable to the larger ones in the
MeCP2+ population, while the prevalence of the smaller neurons
in both genotypes is similar. This indicates that mutant MeCP2
may limit the size of neurons, but does not decrease the size of
MeCP2− somata beyond that of the smallest subset of MeCP2+
neurons.
Recent studies have found that MeCP2 controls nuclear size in
a largely cell-autonomous manner (Singleton et al., 2011; Yazdani
et al., 2012). We ﬁnd signiﬁcant diﬀerences in the average sizes of
somata and nuclei between MeCP2+ and MeCP2− neurons in
the heterozygous brain, which appears to support this hypothe-
sis. However, when comparingMeCP2+ cells in the heterozygous
female brain to MeCP2 WT cells in the wild-type brain, we also
ﬁnd a signiﬁcant diﬀerence in cell size, with neurons from the
wild-type brain being considerably larger. This suggests addi-
tional non-cell autonomous mechanisms for the regulation of cell
size by MeCP2, which may have a detrimental eﬀect on MeCP2+
cell size in the heterozygous brain (Wu et al., 2014). This is an
intriguing observation, since most studies to date have not exam-
ined neuron morphology in heterozygous females. Additionally,
we found that while we needed only a small sample size to conﬁ-
dently avoid type 2 errors for comparisons betweenMeCP2+ and
MeCP2− cells in heterozygous brains, a relatively large sample
size (n>8) was required to demonstrate signiﬁcant diﬀerences
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between MeCP2-positive cells in Mecp2+/− and Mecp2+/+ lit-
termate pairs. This may partially explain why we were able to
note diﬀerences in MeCP2+ cell size between wild-type and
heterozygous animals, but were not able to note similar non-cell
autonomous diﬀerences in dendrtitic morphology.
An Effect of XCI Ratios on Soma and
Nuclear Areas
Previous research has suggested that mutations in MeCP2
may act non-cell-autonomously to aﬀect dendritic morphol-
ogy through the secretion of inhibitory substances by MeCP2-
deﬁcient glia (Ballas et al., 2009; Maezawa et al., 2009; Maezawa
and Jin, 2010). Braunschweig et al. (2004) report that as the num-
ber ofMeCP2− neurons in the femaleMecp2+/− brain increases,
the expression of MeCP2 in MeCP2+ neurons decreases pro-
portionally, suggesting that in addition to cell-autonomous
genotype-speciﬁc eﬀects,Mecp2mutations can negatively impact
neurons through actions of surrounding MeCP2− neurons
and/or glia. When comparing MeCP2 WT neuron size (soma
and nuclear) in wild-type animals to that of MeCP2+ neurons in
heterozygous females, (Figure 11) we see evidence of a non-cell-
autonomous eﬀect, in which the presence of MeCP2− cells in the
brain is associated with reduced cell size for MeCP2+ neurons.
Comparing MeCP2+ to MeCP2− neurons across XCI ratios
presents a more complex picture, however, particularly when
between-animal diﬀerences are normalized by within-animal
comparisons. As the proportion of MeCP2− neurons in the
brain decreases MeCP2+ neurons tend to get larger (consistent
with non-cell-autonomous eﬀects). However, MeCP2− soma
and nuclear size tend to either not change or decrease, despite
an increasing “wild-type” brain environment, resulting in a
strong inverse relationship between XCI ratio and the ratio of
MeCP2−/MeCP2+ cell size, shown in Figure 10C. Given that
soma size has been reported to correlate with dendritic complex-
ity (Kaufmann et al., 1995), these data may support a model in
which MeCP2− neurons ﬁnd it diﬃcult to compete for connec-
tions in female brains with a highly skewed XCI ratio where the
MeCP2+ neurons predominate. One hypothesis is that the con-
sequent inability to compete for synaptic connections reduces
the size of MeCP2− neurons to a greater degree than cell-
autonomous eﬀects alone. In contrast, in females with a balanced
XCI ratio, the “Hebbian” synaptic environment is less com-
petitive overall therefore allowing MeCP2− neurons to make
more contacts with other neurons (Figure 13). Alternatively or
additionally MeCP2− neurons may simply be unable to beneﬁt
from the more wild-type brain environment as the proportion of
wild-type neurons increases with highly skewed XCI. Regardless
of the cause, the result is that the cell-autonomous eﬀects of
MeCP2 mutation dominate even in a predominantly wild-type
environment.
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